Company Filing History:
2 out of 102 
1 out of 416 
Years Active: 2014-2017
Title: Takashi Shirakawa: Innovating in Antibody Development
Introduction
Takashi Shirakawa, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of immunology through his innovative work on antibodies. With a total of two patents to his name, Shirakawa has been instrumental in advancing techniques for detecting and measuring substances with high sensitivity.
Latest Patents
One of Shirakawa's notable patents is for an "Antibody Against Affinity Complex." This invention provides a sensitive methodology for measuring substances, particularly small ones, by utilizing a sandwich method. The patent details an antibody designed to specifically bind to an affinity complex, thus facilitating accurate measurement. The antibody may be a full-length antibody or include regions derived from animals with gene conversion capabilities.
Another significant patent is his development of an "Anti-(Influenza A Virus Subtype H5 Hemagglutinin) Monoclonal Antibody." This invention outlines a method for immunoassaying the H5 subtype influenza A virus, even in cases of considerable genetic mutation. The patent describes a novel monoclonal antibody capable of binding to the hemagglutinin of the H5 subtype, which is vital for effective immunoassay techniques.
Career Highlights
Shirakawa has had an impressive career, working with notable organizations such as Fujirebio Inc. and the National University Corporation Hokkaido University. Through these roles, he has been able to leverage his expertise in antibody research, contributing to the development of groundbreaking immunoassays and methodology.
Collaborations
During his career, Takashi Shirakawa has collaborated with respected colleagues including Yoshiaki Uchida and Hiroshi Kida. Their partnerships have led to advancements in research and innovation in immunology, reflecting the collaborative nature of scientific progress.
Conclusion
Takashi Shirakawa's contributions to the field of immunology through his innovative patents signify the importance of advancing techniques for disease detection and treatment. His work continues to influence research institutions and companies alike, paving the way for future advancements in antibody technology.